Ambrx (AMAM) Provides Safety and Efficacy Data from Ongoing

Ambrx (AMAM) Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress

Ambrx (AMAM) Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Madrid , Spain , Danielj Oconnor , Shawn Zhang , David Mills , Scottt Tagawa , John Shen , Nasdaq , Ambrx Biopharma Inc , European Society Of Medical Oncology , Ambrx Biopharma , Medical Oncology , Key Opinion Leader , First In Human Phase , Chief Executive Officer , Prostate Cancer Poster , Basic Science Poster ,